Back to top
more

Labcorp (LH)

(Delayed Data from NYSE)

$216.00 USD

216.00
308,627

+0.93 (0.43%)

Updated Oct 4, 2024 04:00 PM ET

After-Market: $216.01 +0.01 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth F Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 32% (171 out of 252)

Industry: Medical - Dental Supplies

Better trading starts here.

Zacks News

LabCorp (LH) to Report Q1 Earnings: What's in the Offing?

With respect to LabCorp's (LH) COVID-19 testing services wing, although extensive vaccine rollouts are ongoing, the resurgence of the virus might have once again boosted testing demand in Q1.

LabCorp (LH) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

LabCorp (LH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Why LabCorp (LH) Could Beat Earnings Estimates Again

LabCorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Here's Why You Should Hold on to LabCorp (LH) Stock Now

Investors are optimistic about LabCorp (LH) backed by its strong diagnostic arm growth and progress in Covance business.

Myriad Genetics' (MYGN) myChoice Gets Additional Reimbursement

Myriad Genetics' (MYGN) myChoice test's additional reimbursement will now make it available for use in first-line treatment of advanced ovarian cancer patients.

Thermo Fisher (TMO) Launches Surveillance Tool for COVID-19

The latest launch of surveillance solution is an extremely timely development by Thermo Fisher (TMO) and is expected to witness fast market adoption.

LabCorp (LH) Banks on Structural Review Plan for Solid Returns

LabCorp (LH) plays a critical role in terms of COVID-19-related developments as well as makes progress in other key therapeutic areas.

Debanjana Dey headshot

5 MedTech Growth Stocks Gaining Ground in 2021 Amid Pandemic

Here are a few MedTech stocks, ABT, HOLX, HRC, IDXX, LMAT, which have held their ground amid the pandemic and can turn out to be wise investment choices for 2021.

LabCorp (LH) Moves 4.9% Higher: Will This Strength Last?

LabCorp (LH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there could be more strength down the road.

The Zacks Analyst Blog Highlights: Quest Diagnostics, LabCorp, InMode, Bioanalytical Systems and Semler Scientific

The Zacks Analyst Blog Highlights: Quest Diagnostics, LabCorp, InMode, Bioanalytical Systems and Semler Scientific

Urmimala Biswas headshot

Fed Eyes Faster Recovery in 2021: 3 MedTech Stocks to Buy

MedTech stocks like INMD, BASI and SMLR are expected to maintain market-beating momentum in 2021.

Trina Mukherjee headshot

3 Stocks to Capitalize on Promising Dental Supplies Industry

Despite the challenges thrown by the COVID-19 pandemic, teledentistry coupled with AI & Robotics should lend support to the Zacks Medical - Dental Supplies industry. MCK, WST and CAH are well-poised to gain from the prospects.

Pacific Biosciences' (PACB) Sequel II Gets Deployed by LabCorp

Pacific Biosciences' (PACB) Sequel II HiFi sequencing gets utilized by LabCorp to detect SARS-COV-2 variants in the United States.

Urmimala Biswas headshot

4 Medical Products Stocks Set to Beat This Earnings Season

Rebound in sales volumes and rise in COVID-19 support products sales make us optimistic about MDT, MASI, XRAY and COO's results.

LabCorp's (LH) New Antigen Test to Spot Active COVID-19 Virus

LabCorp's (LH) new antigen test is the newest development to detect COVID-19 infection at every single stage, from diagnostic testing to vaccination trails.

LabCorp (LH) Q4 Earnings Beat Estimates, Margins Expand

LabCorp's (LH) 2021 guidance projects significant downfall in COVID-related testing revenues.

LabCorp (LH) Q4 Earnings and Revenues Beat Estimates

LabCorp (LH) delivered earnings and revenue surprises of 31.18% and 12.94%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

Trina Mukherjee headshot

Medical Products' Feb 11 Earnings Roster: DXCM, LH & More

The Medical Product companies' fourth-quarter results are likely to reflect huge adoption of COVID-19 related healthcare-support products and services despite the impact of the ongoing pandemic.

Why LabCorp (LH) Might Surprise This Earnings Season

LabCorp (LH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Higher Testing Volume to Aid LabCorp's (LH) Q4 Earnings

LabCorp's (LH) fourth-quarter base-business performance is expected to have registered slower recovery rate compared to the third quarter.

Accuray (ARAY) Releases Encouraging Breast Cancer Study Results

Accuray (ARAY) releases positive data from a prospective trial of 338 women with low-risk breast cancer.

Why LabCorp (LH) is Poised to Beat Earnings Estimates Again

LabCorp (LH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Urmimala Biswas headshot

Testing Space in Focus Again Thanks to New Wave of Coronavirus

The resurgence in coronavirus infections is drawing attention back to the diagnostic testing space.

LabCorp's (LH) Covance Arm Stays Robust Amid Procedure Delay

Apart from COVID-19 supports, LabCorp (LH) is making significant strides in other businesses.

Top Ranked Growth Stocks to Buy for January 4th

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 4th.